Featured news in The Life Sciences Report



Celgene Corp. (CELG:NASDAQ)
Corcept Initiates Phase III Study for Cushing's Syndrome (11/20/2018)

view
 


BrainStorm Cell Therapeutics Inc. (BCLI:NASDAQ)
Detailed Research: Economic Perspectives on Stellar Biotechnologies, MAM Software Group, EverQuote, Brainstorm Cell Therapeutics, Mid-Con Energy Partners, LP, and Staffing 360 Solutions - What Drives Growth in Today's Competitive Landscape (11/21/2018)

view
 


ProMIS Neurosciences Inc. (PMN:TSX; PMN:NCM)
ProMIS Neurosciences Issues Year-to Date Update, Highlighting 2018 Accomplishments (11/20/2018)

view
 


Sproutly Canada Inc. (SPR:CSE; SRUTF:OTCQB)
Sproutly Canada, Inc. Subsidiary, Toronto Herbal Remedies, Receives License to Sell to Other Licensed Producers and Expands Growth Production Footprint (11/20/2018)

view
 

Sproutly Canada Inc. (SPR:CSE; SRUTF:OTCQB)
Sproutly Canada, Inc. (OTC: SRUTF) (CSE: SPR) (FRA: 38G) is "One to Watch" (11/19/2018)

view
 


Avivagen Inc. (VIV:TSX.V; VIVXF:OTCQB)
Avivagen Announces Clarification to Press Release Issued November 19, 2018 (11/19/2018)

view
 


Celgene Corp. (CELG:NASDAQ)
Today's Research Reports on Trending Tickers: Celgene and Tesaro (11/20/2018)

view
 


MiMedx Group Inc. (MDXG:NASDAQ)
4 Healthcare Stocks You Should Get To Know Before 2019 (11/20/2018)

view
 


Cesca Therapeutics Inc. (KOOL:NASDAQ)
Cesca Therapeutics Receives 510(k) Clearance to Market Its AXP® II AutoXpress® Platform for Clinical Cord Blood Banking (11/19/2018)

view
 


Sproutly Canada Inc. (SPR:CSE; SRUTF:OTCQB)
Chief Science Officer, Dr. Arup Sen of Sproutly Canada Inc. (CSE: SPR) (OTCQB: SRUTF) at Podcaster Row, MJBizCon, Talks about Unique Water-Soluble Technology and the Ability to Create Designer Cannabis Beverages (11/19/2018)

view
 

Sproutly Canada Inc. (SPR:CSE; SRUTF:OTCQB)
Sproutly Canada Inc. reaches new 52-Week Low (11/16/2018)

view
 


DURECT Corp. (DRRX:NASDAQ)
DURECT Announces Amendment to Accelerate Ongoing Phase 2a Trial of DUR-928 in Alcoholic Hepatitis (AH) by Allowing Dosing of Severe AH Patients in Parallel to Moderate AH Patients (11/19/2018)

view
 


Avivagen Inc. (VIV:TSX.V; VIVXF:OTCQB)
Avivagen's Asian partner UNAHCO continues to ramp-up use of OxC-beta(TM) Livestock with new large order (11/19/2018)

view
 


BrainStorm Cell Therapeutics Inc. (BCLI:NASDAQ)
BrainStorm Cell Therapeutics Announces Submission of IND for NurOwn® in Progressive Multiple Sclerosis (11/19/2018)

view